(R)-1-Boc-3-methylpiperazine
CAS:163765-44-4
Formula:
C10H20N2O2
Purity:
>98.0%(GC)(T)
Color and Shape:
White to Light yellow powder to crystal
Molecular weight:
200.28
Ref: 3B-M3462
5g | 39.00 € | |
25g | 123.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
(R)-(+)-1-Boc-3-methylpiperazine, 97%
CAS:163765-44-4
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. …
Formula:
C10H20N2O2
Purity:
97%
Color and Shape:
Crystals or powder or crystalline powder, White to pale pink
Molecular weight:
200.28
Ref: 02-H27350
1g | 77.00 € | |
5g | 228.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
(R)-4-Boc-2-Methylpiperazine
CAS:163765-44-4
Formula:
C10H20N2O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
200.2780
Ref: AN-AG0032F9
1g | 21.00 € | |
5g | 27.00 € | |
10g | 44.00 € | |
25g | 61.00 € | |
100g | 139.00 € | |
500g | 635.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
(3R)-3-Methylpiperazine, N1-BOC protected
CAS:163765-44-4
Formula:
C10H20N2O2
Purity:
By gc: 99.9% (Typical Value in Batch COA)
Color and Shape:
pale yellow powder
Molecular weight:
200.28g/mol
Ref: 54-OR15642
5g | 29.00 € | |
25g | 60.00 € | |
100g | 177.00 € |
Estimated delivery in United States, on Wednesday 22 May 2024
(R)-4-N-Boc-2-Methyl-piperazine
CAS:163765-44-4
Purity:
97.0%
Color and Shape:
Solid
Molecular weight:
200.28199768066406
Ref: 10-F011517
1g | 17.00 € | |
5g | 17.00 € | |
10g | To inquire | |
25g | 52.00 € | |
100g | 113.00 € | |
500g | 487.00 € |
Estimated delivery in United States, on Friday 31 May 2024
(R)-4-Boc-2-methylpiperazine
CAS:163765-44-4
(R)-4-Boc-2-methylpiperazine is a picolinamide dehydrogenase inhibitor that is used to treat type 2 diabetes. It …
Formula:
C10H20N2O2
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
200.28 g/mol
Ref: 3D-FB72434
10g | 68.00 € | |
25g | 108.00 € | |
50g | 198.00 € | |
100g | 325.00 € | |
250g | 565.00 € |
Estimated delivery in United States, on Monday 3 Jun 2024